Skip to main content
VCbacked
Log inGet Started

MapLight Therapeutics

Palo Alto, United States

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

$372.5M raised
Jul 2025
Series D
BiopharmaBiotechnologyLife ScienceMedical

Top Investors

Blue OwlSanofiNovo Holdings5AM VenturesT. Rowe Price

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MapLight Therapeutics

How much funding has MapLight Therapeutics raised?
MapLight Therapeutics has raised $372.5M in total funding. The most recent round was Series D. The last funding was announced in July 2025.
Who are MapLight Therapeutics's investors?
MapLight Therapeutics's investors include Blue Owl, Sanofi, Novo Holdings, 5AM Ventures, T. Rowe Price.
Where is MapLight Therapeutics headquartered?
MapLight Therapeutics is headquartered in Palo Alto, United States.
What does MapLight Therapeutics do?
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
What stage is MapLight Therapeutics at?
MapLight Therapeutics is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"MapLight Therapeutics — Funding & Investors." VCBacked, July 28, 2025, https://www.vcbacked.co/company/maplight-therapeutics. Accessed June 7, 2026.
APA
VCBacked. (2025). MapLight Therapeutics — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/maplight-therapeutics
Wikipedia (cite web)
{{cite web |title=MapLight Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/maplight-therapeutics |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego